advanced Hodgkin’s Lymphoma

May 14, 2019

Health Canada Approves Adcetris-Chemo for Advanced Classical Hodgkin’s Lymphoma

News

Health Canada has approved Seattle Genetics‘ submission requesting approval of Adcetris (brentuximab vedotin) in combination with standard chemotherapy as a frontline treatment for patients with advanced (stage IV) classical Hodgkin’s lymphoma. ... Read more

September 12, 2018

Corticosteroid Use May Cause Bone Side Effects in Hodgkin’s Lymphoma Patients, Study Suggests

News

Corticosteroid use is among the risk factors leading to osteonecrosis — a painful, bone-disrupting condition — in Hodgkin’s lymphoma patients, a large retrospective analysis shows. Given that no proven interventions ... Read more

February 1, 2018February 1, 2018

Adcetris-Chemo Combo Delays Disease Progression in Newly-diagnosed Advanced Lymphoma, Trial Shows

News

Results from a Phase 3 clinical trial show that adding Adcetris (brentuximab vedotin) to a chemotherapy regimen reduces the risk of disease progression, death, or use of additional anticancer therapies for ... Read more

June 29, 2017June 29, 2017

Adcetris-Chemotherapy Combo Lengthens the Time for Hodgkin’s Lymphoma to Progress, Trial Shows

News

Adding Adcetris (brentuximab vedotin) to standard chemotherapy significantly lengthens the time it takes for Hodgkin’s lymphoma to progress, or for a patient to die, according to an updated of Phase 3 clinical ... Read more